Skip to main content

Remote Job Finders (RJF)

When Ingram became Sarepta Therapeutics’ CEO in 2017, he didn’t have a connection to muscular dystrophy, but he has developed a fierce passion for the therapeutic area. He will step aside from his role to dedicate more time to his family.
Sarepta CEO Doug Ingram To Step Down as Muscular Dystrophy Mission Hits Home
Scroll to top